Coronavirus updates: 23-year-old college student dies from COVID-19
Jamesha Waddell, a senior at Livingstone College, died Thursday.
A pandemic of the novel coronavirus has now killed more than 1.3 million people worldwide.
Over 58.7 million people across the globe have been diagnosed with COVID-19, the disease caused by the new respiratory virus, according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. The actual numbers are believed to be much higher due to testing shortages, many unreported cases and suspicions that some national governments are hiding or downplaying the scope of their outbreaks. The criteria for diagnosis -- through clinical means or a lab test -- has also varied from country to country.
The United States is the worst-affected nation, with more than 12.2 million diagnosed cases and at least 256,783 deaths.
Nearly 200 vaccine candidates for COVID-19 are being tracked by the World Health Organization, at least 10 of which are in crucial phase three studies. Of those 10 potential vaccines in late-stage trials, there are currently five that will be available in the United States if approved.
Latest headlines:
Donald Trump Jr. has tested positive for COVID-19
Donald Trump. Jr. is the latest person connected to the White House to test positive for the coronavirus, a spokesman confirmed to ABC News.
“Don tested positive at the start of the week and has been quarantining out at his cabin since the result. He’s been completely asymptomatic so far and is following all medically recommended COVID-19 guidelines,” the spokesman said in a statement.
The president's eldest son is the second of his children to test positive for the virus, following Barron Trump's diagnosis last month.
ABC News' John Santucci contributed to this report
FDA to review Pfizer vaccine on Dec. 10
The U.S. Food and Drug Administration announced Thursday that its vaccine advisory committee will meet Dec. 10 to discuss the request for emergency use authorization of Pfizer's COVID-19 vaccine candidate.
The public meeting will be a chance for both FDA career scientists and members of the independent advisory board to ask Pfizer questions about its product.
After that, the board will make a recommendation, which the FDA will take into account when it decides whether to authorize the vaccine.
Officials said they cannot predict how long the FDA's review will take, but that it will be "as expeditiously as possible, while still doing so in a thorough and science-based manner."
ABC News' Anne Flaherty contributed to this report
California sets new record with more than 13,000 daily cases
California broke its daily case record with 13,005 newly recorded cases.
California's seven-day positivity rate stands at 5.9%.
With over 1.07 million cases, California trails only Texas, which last reported 1.1 million cases.
ABC News' Alex Stone contributed to this report.
FDA could approve emergency use of Pfizer vaccine in December
Pfizer said it's completed its submission to the Food and Drug Administration in which the company requests emergency use authorization for its vaccine.
The FDA is expected to start digging into the efficacy and safety data immediately, and it could make a decision as early as mid-December.
ABC News' Sony Salzman contributed to this report.